Decision tree analyses of key patient characteristics in Middle Eastern/North African and Latin American men treated with long-acting and short-acting PDE5 inhibitors for erectile dysfunction

References

• Berrada S, Kadri N, Mechakra-Tahiri S, et al. Prevalence of erectile dysfunction and its correlates: a population-based study in Morocco. Int J Impot Res 2003;15:S3-7
   PubMed Web of Science ®Google Scholar
• Shaeer O. The Global Online Sexuality Survey (GOSS): the United States of America in 2011 chapter II: phosphodiesterase inhibitors utilization among English speakers. J Sex Med 2013;10:532-40
   PubMed Web of Science ®Google Scholar
• Reporters and participants of the 1st Latin American Erectile Dysfunction Consensus Meeting. Chapter 1: erectile dysfunction epidemiology. Int J Impot Res 2003;15(Suppl 7):S2-4
   PubMedGoogle Scholar
• Morillo LE, Diaz J, Estevez E, et al. Prevalence of erectile dysfunction in Columbia, Ecuador, and Venezuela: a population-based study (DENSA). Int J Impot Res 2002;14:S10-18
   PubMed Web of Science ®Google Scholar
• Nolazco C, Bellora O, Lopez M, et al. Prevalence of sexual dysfunctions in Argentina. Int J Impot Res 2004;16:69-72
   PubMed Web of Science ®Google Scholar
• Hatzimouratidis K, Amar E, Eardley I, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010;57:804-14
   PubMed Web of Science ®Google Scholar
• Shaeer O, Shaeer K. The Global Online Sexuality Survey (GOSS): erectile dysfunction among Arabic-speaking internet users in the Middle East. J Sex Med 2011;8:2152-60
   PubMed Web of Science ®Google Scholar
• Conaglen HM, Conaglen JV. Couples’ reasons for adherence to, or discontinuation of, PDE type 5 inhibitors for men with erectile dysfunction at 12- and 24-month follow-up after a 6-month free trial. J Sex Med 2012;9:857-65
   PubMed Web of Science ®Google Scholar
• Carvalheira AA, Pereira NM, Maroco J, Forjaz V. Dropout in the treatment of erectile dysfunction with PDE5: a study on predictors and qualitative analysis of reasons for discontinuation. J Sex Med 2012;9:2361-9
   PubMed Web of Science ®Google Scholar
• El-Meliegy A, Rabah D, Al-Mitwalli K, et al. A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction. Curr Med Res Opin 2013;29:707-17
   PubMed Web of Science ®Google Scholar
• Rubio-Aurioles E, Reyes LA, Borregales L, et al. A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Latin American men with erecitle dysfunction. Curr Med Res Opin 2013;29:695-706
   PubMed Web of Science ®Google Scholar
• Eardley I, Montorsi F, Jackson G, et al. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study. BJU Int 2007;100:122-9
   PubMed Web of Science ®Google Scholar
• Perimenis P, Roumeguere T, Heidler H, et al. Evaluation of patient expectations and treatment satisfaction after 1-year tadalafil therapy for erectile dysfunction: the DETECT study. J Sex Med 2009;6:257-67
   PubMed Web of Science ®Google Scholar
• Yeaw J, Benner JS, Walt JG, et al. Comparing adherence and persistence across 6 chronic medication classes. J Managed Care Pharm 2009;15:728-40
   Google Scholar
• World Health Organization. Adherence to long-term therapies, 2003. Available at: http://whqlibdoc.who.int/publications/2003/9241545992.pdf [Last accessed 24 September 2013]
   Google Scholar
• Cappelleri JC, Althof SE, Siegel RL, et al. Development and validation of the Self-Esteem and Relationship questionnaire in erectile dysfunction. Int J Impot Res 2004;16:30-8
   PubMed Web of Science ®Google Scholar
• Althof SE, Corty EW, Levine SB, et al. EDITS: development of a questionnaire for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999;53:793-9
   PubMed Web of Science ®Google Scholar
• Shariat SF, Karakiewicz PI, Suardi N, et al. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res 2008;14:4400-7
   PubMed Web of Science ®Google Scholar
• Brock G, Glina S, Mncada I, et al. Likelihood of tadalafil-associated adverse events in integrated multiclinical trial database: classification tree analysis in men with erectile dysfunction. J Urol 2009;73:756-61
   Google Scholar
• R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2012. Available at: http://www.R-project.org/ [Last accessed 24 September 2013]
   Google Scholar
• Therneau T, Atkinson B, Ripley B. rpart: Recursive Partitioning. R package version 4.0-1, 2012. Available at: http://CRAN.R-project.org/package=rpart [Last accessed 24 September 2013]
   Google Scholar
• Milborrow S. rpart.plot: Plot rpart Models. An Enhanced Version of plot.rpart. R package version 1.4-3, 2012. Available at: http://CRAN.R-project.org/package=rpart.plot [Last accessed 24 September 2013]
   Google Scholar
• Verheyden B, Roumeguere T, Bitton A, et al, for the DETECT study investigators. Effects of 12-month tadalafil therapy for erectile dysfunction on couple relationships: results from the DETECT study. J Sex Med 2009;6:3458-68
   PubMed Web of Science ®Google Scholar
• Bhavsar V, Bhugra D. Cultural factors and sexual dysfunction in clinical practice. Adv Psych Treat 2013;19:144-52
   Google Scholar
• Barzoki MH, Seyedroghani N, Azadarmaki T. Sexual dissatisfaction in a sample of married Iranian women. Sex Cult 2013;17:244-59
   Google Scholar
• Moreira Junior ED, Glasser D, Santos DB, et al. Prevalence of sexual problems and related help-seeking behaviors among mature adults in Brazil: data from the global study of sexual attitudes and behaviors. Sao Paulo Med J 2005;123:234-41
   PubMedGoogle Scholar
• Sand M, Fisher W, Rosen R, et al. Erectile dysfunction and constructs of masculinity and quality of life in the multinational men’s attitudes to life events and sexuality (MALES) study. J Sex Med 2008;5:583-94
   PubMed Web of Science ®Google Scholar
• Hatzichristou D, Haro JM, Martin-Morales A, et al. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study. Int J Clin Pract 2007;61:1850-62
   PubMed Web of Science ®Google Scholar
• Martin-Morales A, Haro JM, Beardsworth A, et al, and the EDOS Group. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the Erectile Dysfunction Observational Study (EDOS). Eur Urol 2007;51:541-50
   PubMed Web of Science ®Google Scholar
• Kim SC. Sexual attitude and perception on sexual relationship among long-term users of sildenafil. J Sex Med 2008;5:2681-7
   PubMed Web of Science ®Google Scholar
• Althof SE, Eid F, Talley DR, et al. Through the eyes of women: the partners’ perspective on tadalafil. Adult Urol 2006;68:631-5
   PubMed Web of Science ®Google Scholar